$3.01B
$3.96 Million
0.0% of portfolio
453,595
Q4 2023
Reduced 24.96%
$868M
$318,000
0.0% of portfolio
34,333
Q4 2023
Added 179.05%
$311M
$16,000
0.0% of portfolio
8,648
Q4 2023
Added 149.17%
$220M
$205,000
0.0% of portfolio
18,897
Q4 2023
Reduced 90.66%
$296M
$3,000
0.0% of portfolio
168
Q4 2023
Reduced 19.64%
$4.98B
$4.67 Million
0.0% of portfolio
229,467
Q4 2023
Added 16.92%
Concentra Group Holdings Par
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 4.58%
$3.15B
$6.84 Million
0.0% of portfolio
122,907
Q4 2023
Added 42.55%
$393M
$11,000
0.0% of portfolio
2,183
Q4 2023
Added 417.73%
$583M
$390,000
0.0% of portfolio
144,554
Q4 2023
Reduced 3.83%
$3.67B
$6.56 Million
0.0% of portfolio
279,704
Q4 2023
Added 46.52%
$1.46B
$5.82 Million
0.0% of portfolio
96,452
Q4 2023
Reduced 4.3%
$985M
$946,000
0.0% of portfolio
38,955
Q4 2023
Reduced 18.4%
$413M
$35,000
0.0% of portfolio
1,531
Q4 2023
Added 3,080.8%
$454M
$109,000
0.0% of portfolio
4,466
Q4 2023
Added 7,112.43%
$2.06B
$349,000
0.0% of portfolio
34,662
Q4 2023
Reduced 47.53%
$4.26B
$3.44 Million
0.0% of portfolio
47,904
Q4 2023
Reduced 11.3%
$181M
$7,000
0.0% of portfolio
810
Q3 2022
Reduced 31.93%
$138M
$9,000
0.0% of portfolio
974
Q4 2023
Reduced 24.13%
Contineum Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 42.52%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.17%
$397M
$22,000
0.0% of portfolio
1,452
Q4 2023
Added 9.09%
$3.14B
$30,000
0.0% of portfolio
330
Q4 2023
Reduced 77.27%
Corbus Pharmaceuticals Hldgs
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.8%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 99.57%
$140M
$8,000
0.0% of portfolio
584
Q4 2023
Reduced 15.73%
Core Natural Resources Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 89.48%
$2.32B
$6.21 Million
0.0% of portfolio
306,089
Q4 2023
Added 4.49%
$451M
$329,000
0.0% of portfolio
53,465
Q4 2023
Reduced 88.45%
-
$0
0.0% of portfolio
-
Q2 2024
Added 5.07%
$892M
$1.07 Million
0.0% of portfolio
120,892
Q4 2023
Reduced 1.27%
$1.62B
$8.65 Million
0.0% of portfolio
77,262
Q4 2023
Reduced 65.88%
$1.14B
$59,000
0.0% of portfolio
6,030
Q4 2023
Reduced 19.62%
$4.25B
$4.13 Million
0.0% of portfolio
755,005
Q4 2023
Added 15.91%
$1.09B
$644,000
0.0% of portfolio
40,904
Q4 2023
Reduced 36.15%
$1.3B
$1.13 Million
0.0% of portfolio
169,912
Q4 2023
Reduced 40.84%
$292M
$310,000
0.0% of portfolio
14,007
Q4 2023
Reduced 47.7%
$235M
$14,000
0.0% of portfolio
499
Q2 2023
New
$1.25B
$1.51 Million
0.0% of portfolio
8,734
Q4 2023
Reduced 10.29%
$1.51B
$2.34 Million
0.0% of portfolio
60,300
Q4 2023
Added 3.13%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 26.95%
$10.5B
$12 Million
0.0% of portfolio
78,103
Q4 2023
Reduced 5.79%
$0
$0
0.0% of portfolio
-
Q4 2023
Reduced 92.41%
$6.71B
$3.81 Million
0.0% of portfolio
7,381
Q4 2023
Added 46.1%
$13.5B
$6.27 Million
0.0% of portfolio
156,228
Q4 2023
Reduced 28.13%
$417M
$5.02 Million
0.0% of portfolio
447,048
Q4 2023
Reduced 85.08%
$23.9B
$0
0.0% of portfolio
-
Q4 2023
Reduced 98.2%
$243M
$263,000
0.0% of portfolio
51,151
Q4 2023
Reduced 51.64%
$1.64B
$2.97 Million
0.0% of portfolio
88,627
Q4 2023
Reduced 38.95%